Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • Vaccine Hub
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
  • Fact Check
  • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Fact Check
      • Bone Health Fact Check
      • Brain Health Fact Check
      • Cancer Related Fact Check
      • Child Care Fact Check
      • Dental and oral health fact check
      • Diabetes and metabolic health fact check
      • Diet and Nutrition Fact Check
      • Eye and ENT Care Fact Check
      • Fitness fact check
      • Gut health fact check
      • Heart health fact check
      • Kidney health fact check
      • Medical education fact check
      • Men's health fact check
      • Respiratory fact check
      • Skin and hair care fact check
      • Vaccine and Immunization fact check
      • Women's health fact check
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Abroad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Fact Check
    • Bone Health Fact Check
    • Brain Health Fact Check
    • Cancer Related Fact Check
    • Child Care Fact Check
    • Dental and oral health fact check
    • Diabetes and metabolic health fact check
    • Diet and Nutrition Fact Check
    • Eye and ENT Care Fact Check
    • Fitness fact check
    • Gut health fact check
    • Heart health fact check
    • Kidney health fact check
    • Medical education fact check
    • Men's health fact check
    • Respiratory fact check
    • Skin and hair care fact check
    • Vaccine and Immunization fact check
    • Women's health fact check
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Abroad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • News
  • Industry
  • Pharma News
  • NPPA Fixes Retail...

NPPA Fixes Retail Price Of 74 Formulations, Details

Dr. Divya ColinWritten by Dr. Divya Colin Published On 2023-02-28T18:00:16+05:30  |  Updated On 28 Feb 2023 6:00 PM IST
NPPA Fixes Retail Price Of 74 Formulations, Details
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • Telegram
  • Email

New Delhi: Through a recent notification, the National Pharmaceutical Pricing Authority (NPPA), the Ministry of Chemicals and Fertilizer, the Government of India has fixed the retail prices of the 74 scheduled formulations including those used to lower the levels of triglycerides in blood, to prevent heart attack and stroke, to treat high blood pressure, type 2 diabetes, and gastro-oesophageal reflux disease.

This came in line with the decision of the 109th authority meeting dated 21.02.2023, where the authority discussed the new drug applications for price fixation under para 5 and 15 of DPCO 2013.

These include Exemed Pharmaceuticals & Sun Pharma's Dapagliflozin, Sitagliptin and Metformin Hydrochloride (as Extended Release) Tablets, Exemed Pharmaceuticals & Mankind Pharma's Dapagliflozin, Sitagliptin and Metformin Hydrochloride (as Extended Release) Tablets, Exemed Pharmaceuticals & Eris Lifesciences Dapagliflozin, Vildagliptin (As Sustained Release) and Metformin Hydrochloride (as Sustained Release) Tablets, Exemed Pharmaceuticals & Intas Pharmaceutical's Dapagliflozin, Vildagliptin (As Sustained Release) and Metformin Hydrochloride (as Sustained Release) Tablets.

The list further includes Ravenbhel Healthcare & Mankind Pharma's Dapagliflozin and Teneligliptin Tablets, Synokem Pharmaceuticals & Eris Lifesciences Teneligliptin, Pioglitazone and Metformin Hydrochloride (as Sustained Release) Tablets, Exemed Pharmaceuticals & Abbott Healthcare's Dapagliflozin, Vildagliptin (As Sustained Release) and Metformin Hydrochloride (as Sustained Release) Tablets etc.

This comes in exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May 2013 and S. O. 5249(E) dated 11th November 2022 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA), hereby fixes, the price as specified in column (6) of the table herein below as the retail price, exclusive of Goods and Services Tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer & marketing company, as specified in the corresponding entries in columns (3) and (5) thereof;

Sl.

No.

Name of the Formulation /

Brand Name

Strength

Unit

Manufacturer & Marketing

Company

Retail Price

(Rs.)

(1)

(2)

(3)

(4)

(5)

(6)

1

Dapagliflozin, Sitagliptin and Metformin Hydrochloride (as Extended Release) Tablets

Each film-coated tablet contains:

Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 10mg Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Metformin Hydrochloride IP 500mg (as Extended

Release)

1 Tablet

M/s Exemed Pharmaceuticals / M/s Sun Pharma Laboratories Limited

27.75

2

Dapagliflozin, Sitagliptin and Metformin Hydrochloride (as Extended Release) Tablets

Each film coated tablet contains:

Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 10mg Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Metformin Hydrochloride IP 500mg (as Extended

Release)

1 Tablet

M/s Exemed Pharmaceuticals / M/s Mankind Pharma Ltd.

27.75

3

Dapagliflozin, Sitagliptin and Metformin Hydrochloride (as Extended Release) Tablets

Each film coated tablet contains:

Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 10mg Sitagliptin Phosphate Monohydrate IP eq. to

Sitagliptin 100mg Metformin Hydrochloride IP

1 Tablet

M/s Exemed Pharmaceuticals / M/s Mankind Pharma Ltd.

29.29


Sl.

No.

Name of the Formulation / Brand Name

Strength

Unit

Manufacturer & Marketing Company

Retail Price (Rs.)

(1)

(2)

(3)

(4)

(5)

(6)

1000mg (as Extended Release)

4

Dapagliflozin, Vildagliptin (As Sustained Release) and Metformin Hydrochloride (as Sustained Release) Tablets

Each film coated bilayered tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 10mg Vildagliptin IP 100mg (As Sustained Release) Metformin Hydrochloride IP 500mg (as Sustained Release)

1 Tablet

M/s Exemed Pharmaceuticals / M/s Eris Lifesciences Limited

14.90

5

Dapagliflozin, Vildagliptin (As Sustained Release) and Metformin Hydrochloride (as Sustained Release) Tablets

Each film coated bilayered tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 10mg Vildagliptin IP 100mg (As Sustained Release) Metformin Hydrochloride IP 500mg (as Sustained Release)

1 Tablet

M/s Exemed Pharmaceuticals / M/s Intas Pharmaceuticals Ltd.

14.90

6

Dapagliflozin, Vildagliptin (As Sustained Release) and Metformin Hydrochloride (as Sustained Release) Tablets

Each film coated bilayered tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 10mg Vildagliptin IP 100mg (As Sustained Release) Metformin Hydrochloride IP 500mg (as Sustained

Release)

1 Tablet

M/s Exemed Pharmaceuticals / M/s USV Pvt. Ltd.

14.90

7

Dapagliflozin, Vildagliptin (As Sustained Release) and Metformin Hydrochloride (as Sustained Release) Tablets

Each film coated bilayered tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 10mg Vildagliptin IP 100mg (As Sustained Release) Metformin Hydrochloride IP 500mg (as Sustained

Release)

1 Tablet

M/s Exemed Pharmaceuticals / M/s Zydus Healthcare Limited

14.90

8

Dapagliflozin, Vildagliptin (As Sustained Release) and Metformin Hydrochloride (as Sustained Release) Tablets

Each film coated bilayered tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 10mg Vildagliptin IP 100mg (As Sustained Release) Metformin Hydrochloride IP 500mg (as Sustained

Release)

1 Tablet

M/s Exemed Pharmaceuticals / M/s Cipla Ltd.

14.90


Sl.

No.

Name of the Formulation / Brand Name

Strength

Unit

Manufacturer & Marketing Company

Retail Price (Rs.)

(1)

(2)

(3)

(4)

(5)

(6)

9

Dapagliflozin, Vildagliptin (As Sustained Release) and Metformin Hydrochloride (as Sustained Release) Tablets

Each uncoated bilayered tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 10mg Vildagliptin IP 100mg (As Sustained Release) Metformin Hydrochloride IP 500mg (as Sustained Release)

1 Tablet

M/s Exemed Pharmaceuticals / M/s Micro Labs Limited

14.79

10

Dapagliflozin, Vildagliptin (As Sustained Release) and Metformin Hydrochloride (as Sustained Release) Tablets

Each film coated bilayered tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 10mg Vildagliptin IP 100mg (As Sustained Release) Metformin Hydrochloride IP

500mg (as Sustained Release)

1 Tablet

M/s Exemed Pharmaceuticals / M/s Lupin Limited

14.79

11

Dapagliflozin, Vildagliptin (As Sustained Release) and Metformin Hydrochloride (as Sustained Release) Tablets

Each film coated bilayered tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 10mg Vildagliptin IP 100mg (As Sustained Release) Metformin Hydrochloride IP 500mg (as Sustained

Release)

1 Tablet

M/s Exemed Pharmaceuticals / M/s Emcure Pharmaceuticals Limited

14.79

12

Dapagliflozin, Vildagliptin (As Sustained Release) and Metformin Hydrochloride (as Sustained Release) Tablets

Each film coated bilayered tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 10mg Vildagliptin IP 100mg (As Sustained Release) Metformin Hydrochloride IP 1000mg (as Sustained

Release)

1 Tablet

M/s Exemed Pharmaceuticals / M/s Intas Pharmaceuticals Ltd.

16.44

13

Dapagliflozin, Vildagliptin (As Sustained Release) and Metformin Hydrochloride (as Sustained Release) Tablets

Each film coated bilayered tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 10mg Vildagliptin IP 100mg (As Sustained Release) Metformin Hydrochloride IP 1000mg (as Sustained

Release)

1 Tablet

M/s Exemed Pharmaceuticals / M/s Eris Lifesciences Limited

16.44

14

Dapagliflozin, Vildagliptin (As Sustained

Release) and

Each film coated bilayered tablet contains: Dapagliflozin Propanediol

Monohydrate eq. to

1 Tablet

M/s Exemed Pharmaceuticals / M/s Zydus

Healthcare Limited

16.44


Sl.

No.

Name of the Formulation / Brand Name

Strength

Unit

Manufacturer & Marketing Company

Retail Price (Rs.)

(1)

(2)

(3)

(4)

(5)

(6)

Metformin Hydrochloride (as Sustained Release) Tablets

Dapagliflozin 10mg Vildagliptin IP 100mg (As Sustained Release) Metformin Hydrochloride IP 1000mg (as Sustained Release)

15

Dapagliflozin, Vildagliptin (As Sustained Release) and Metformin Hydrochloride (as Sustained Release) Tablets

Each film coated bilayered tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 10mg Vildagliptin IP 100mg (As Sustained Release) Metformin Hydrochloride IP 1000mg (as Sustained Release)

1 Tablet

M/s Exemed Pharmaceuticals / M/s Cipla Ltd.

16.44

16

Dapagliflozin, Vildagliptin (As Sustained Release) and Metformin Hydrochloride (as Sustained Release) Tablets

Each film coated bilayered tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 10mg Vildagliptin IP 100mg (As Sustained Release) Metformin Hydrochloride IP 1000mg (as Sustained

Release)

1 Tablet

M/s Exemed Pharmaceuticals / M/s USV Pvt. Ltd.

16.44

17

Dapagliflozin, Vildagliptin (As Sustained Release) and Metformin Hydrochloride (as Sustained Release) Tablets

Each film coated bilayered tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 10mg Vildagliptin IP 100mg (As Sustained Release) Metformin Hydrochloride IP 1000mg (as Sustained

Release)

1 Tablet

M/s Exemed Pharmaceuticals / M/s Lupin Limited

16.33

18

Dapagliflozin, Vildagliptin (As Sustained Release) and Metformin Hydrochloride (as Sustained Release) Tablets

Each film coated bilayered tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 10mg Vildagliptin IP 100mg (As Sustained Release) Metformin Hydrochloride IP 1000mg (as Sustained

Release)

1 Tablet

M/s Exemed Pharmaceuticals / M/s Emcure Pharmaceuticals Limited

16.33

19

Dapagliflozin, Vildagliptin (As Sustained Release) and Metformin Hydrochloride (as Sustained

Release)

Each uncoated bilayered tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 10mg Vildagliptin IP 100mg (As Sustained Release)

Metformin Hydrochloride IP

1 Tablet

M/s Exemed Pharmaceuticals / M/s Micro Labs Limited

16.33


Sl.

No.

Name of the Formulation / Brand Name

Strength

Unit

Manufacturer & Marketing Company

Retail Price (Rs.)

(1)

(2)

(3)

(4)

(5)

(6)

Tablets

1000mg (as Sustained Release)

20

Dapagliflozin, Vildagliptin (As Sustained Release) and Metformin Hydrochloride (as Sustained Release) Tablets

Each uncoated bilayered tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 10mg Vildagliptin IP 100mg (As Sustained Release) Metformin Hydrochloride IP 1000mg (as Sustained Release)

1 Tablet

M/s Exemed Pharmaceuticals / M/s Abbott Healthcare Pvt. Ltd.

16.38

21

Dapagliflozin, Vildagliptin (As Sustained Release) and Metformin Hydrochloride (as Sustained Release) Tablets

Each uncoated bilayered tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 10mg Vildagliptin IP 100mg (As Sustained Release) Metformin Hydrochloride IP

500mg (as Sustained Release)

1 Tablet

M/s Exemed Pharmaceuticals / M/s Abbott Healthcare Pvt. Ltd.

14.84

22

Sitagliptin and Metformin Hydrochloride (as Extended Release) Tablets

Each film coated bilayered tablet contains:

Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Metformin Hydrochloride IP

500mg (as Extended Release)

1 Tablet

M/s Pure and Cure Healthcare Pvt. Ltd.

/ M/s Abbott Healthcare Pvt. Ltd.

15.65

23

Sitagliptin and Metformin Hydrochloride (as Extended Release) Tablets

Each film coated bilayered tablet contains:

Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Metformin Hydrochloride IP 500mg (as Extended

Release)

1 Tablet

M/s Ravenbhel Healthcare Pvt. Ltd.

/ M/s Lupin Limited

19.45

24

Teneligliptin,Pi oglitazone & Metformin Hydrochloride (Sustained Release) Tablets

Each film coated bilayered tablet contains: Teneligliptin Hydrobromide Hydrate IP eq. to Teneligliptin 20mg Pioglitazone Hydrochloride IP eq. to Pioglitazone 15mg Metformin Hydrochloride IP 500mg (As Sustained

Release)

1 Tablet

M/s Synokem Parmaceuticals Ltd.

/ M/s Glenmark Pharmaceuticals Limited

16.01

25

Teneligliptin, Pioglitazone and Metformin Hydrochloride (as Sustained

Release)

Each Film coated bilayered tablet contains: Teneligliptin Hydrobromide Hydrate IP eq. to Teneligliptin 20mg

Pioglitazone Hydrochloride

1 Tablet

M/s Synokem Pharmaceuticals Limited / M/s Eris Lifesciences Limited

16.01


Sl.

No.

Name of the Formulation / Brand Name

Strength

Unit

Manufacturer & Marketing Company

Retail Price (Rs.)

(1)

(2)

(3)

(4)

(5)

(6)

Tablets

IP eq. to Pioglitazone 15mg Metformin Hydrochloride IP 500mg (as Sustained Release)

26

Teneligliptin,Pioglitazone & Metformin Hydrochloride (Sustained Release) Tablets

Each film coated bilayered tablet contains: Teneligliptin Hydrobromide Hydrate IP eq. to Teneligliptin 20mg Pioglitazone Hydrochloride IP eq. to Pioglitazone 15mg Metformin Hydrochloride IP 1000mg (As Sustained Release)

1 Tablet

M/s Synokem Parmaceuticals Ltd.

/ M/s Glenmark Pharmaceuticals Limited

17.55

27

Teneligliptin, Pioglitazone and Metformin Hydrochloride (as Sustained Release) Tablets

Each Film coated bilayered tablet contains: Teneligliptin Hydrobromide Hydrate IP eq. to Teneligliptin 20mg Pioglitazone Hydrochloride IP eq. to Pioglitazone 15mg Metformin Hydrochloride IP

1000mg (as Sustained Release)

1 Tablet

M/s Synokem Pharmaceuticals Limited / M/s Eris Lifesciences Limited

17.55

28

Dapagliflozin and Teneligliptin Tablets

Each film coated tablet contains:

Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 5mg Teneligliptin Hydrobromide Hydrate IP eq. to

Teneligliptin 20mg

1 Tablet

M/s Ravenbhel Healthcare Pvt. Ltd.

/ M/s Mankind Pharma Limited

14.50

29

Dapagliflozin and Teneligliptin Tablets

Each film coated tablet contains:

Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 10mg Teneligliptin Hydrobromide Hydrate IP eq. to

Teneligliptin 20mg

1 Tablet

M/s Ravenbhel Healthcare Pvt. Ltd.

/ M/s Mankind Pharma Limited

15.83

30

Bisoprolol Fumerate & Telmisartan Tablets

Each uncoated bilayered tablet contains: Bisoprolol Fumerate IP 2.5mg

Telmisartan IP 40mg

1 Tablet

M/s Windlas Biotech Limited / M/s Merck Specialities Pvt Ltd.

10.92

31

Telmisartan and Bisoprolol Fumarate Tablets

Each film coated tablet contains:

Telmisartan IP 40mg Bisoprolol Fumarate IP

2.5mg

1 Tablet

M/s Ravenbhel Healthcare Pvt. Ltd.

/ M/s Torrent Pharmaceuticals

Ltd.

10.92

32

Telmisartan and Bisoprolol Fumarate Tablets

Each film coated tablet contains:

Telmisartan IP 40mg

Bisoprolol Fumarate IP

1 Tablet

M/s Ravenbhel Healthcare Pvt. Ltd.

/ M/s Glenmark

Pharmaceuticals

10.92


Sl.

No.

Name of the Formulation / Brand Name

Strength

Unit

Manufacturer & Marketing Company

Retail Price (Rs.)

(1)

(2)

(3)

(4)

(5)

(6)

2.5mg

Ltd.

33

Telmisartan and Bisoprolol Fumarate Tablets

Each film coated tablet contains:

Telmisartan IP 40mg Bisoprolol Fumarate IP

2.5mg

1 Tablet

M/s Ravenbhel Healthcare Pvt. Ltd.

/ M/s Alkem Laboratories Ltd.

10.92

34

Telmisartan and Bisoprolol Fumarate Tablets

Each film coated tablet contains:

Telmisartan IP 40mg Bisoprolol Fumarate IP

2.5mg

1 Tablet

M/s Ravenbhel Healthcare Pvt. Ltd.

/ M/s Lupin Limited

10.92

35

Telmisartan and Bisoprolol Fumarate Tablets

Each film coated tablet contains:

Telmisartan IP 40mg Bisoprolol Fumarate IP

2.5mg

1 Tablet

M/s Ravenbhel Healthcare Pvt. Ltd.

/ M/s Eris lifesciences Limited

10.92

36

Telmisartan and Bisoprolol Fumarate Tablets

Each film coated tablet contains:

Telmisartan IP 40mg

Bisoprolol Fumarate IP 2.5mg

1 Tablet

M/s Ravenbhel Healthcare Pvt. Ltd.

/ M/s Mankind Pharma Limited

10.92

37

Bisoprolol Fumerate & Telmisartan Tablets

Each uncoated bilayered tablet contains:

Bisoprolol Fumerate IP 5mg

Telmisartan IP 40mg

1 Tablet

M/s Windlas Biotech Limited / M/s Merck Specialities Pvt Ltd.

12.52

38

Telmisartan and Bisoprolol Fumarate Tablets

Each film coated tablet contains:

Telmisartan IP 40mg Bisoprolol Fumarate IP 5mg

1 Tablet

M/s Ravenbhel Healthcare Pvt. Ltd.

/ M/s Torrent

Pharmaceuticals Ltd.

12.52

39

Telmisartan and Bisoprolol Fumarate Tablets

Each film coated tablet contains:

Telmisartan IP 40mg Bisoprolol Fumarate IP 5mg

1 Tablet

M/s Ravenbhel Healthcare Pvt. Ltd.

/ M/s Glenmark Pharmaceuticals

Ltd.

12.52

40

Telmisartan and Bisoprolol Fumarate Tablets

Each film coated tablet contains:

Telmisartan IP 40mg

Bisoprolol Fumarate IP 5mg

1 Tablet

M/s Ravenbhel Healthcare Pvt. Ltd.

/ M/s Alkem

Laboratories Ltd.

12.52

41

Telmisartan and Bisoprolol Fumarate Tablets

Each film coated tablet contains:

Telmisartan IP 40mg

Bisoprolol Fumarate IP 5mg

1 Tablet

M/s Ravenbhel Healthcare Pvt. Ltd.

/ M/s Lupin Limited

12.52

42

Telmisartan and Bisoprolol Fumarate Tablets

Each film coated tablet contains:

Telmisartan IP 40mg

Bisoprolol Fumarate IP 5mg

1 Tablet

M/s Ravenbhel Healthcare Pvt. Ltd.

/ M/s Eris

lifesciences Limited

12.52

43

Telmisartan and Bisoprolol Fumarate Tablets

Each film coated tablet contains:

Telmisartan IP 40mg

Bisoprolol Fumarate IP 5mg

1 Tablet

M/s Ravenbhel Healthcare Pvt. Ltd.

/ M/s Mankind

Pharma Limited

12.52

44

Telmisartan and Bisoprolol Fumarate

Each film coated tablet contains:

Telmisartan IP 40mg

1 Tablet

M/s Ravenbhel Healthcare Pvt. Ltd.

/ M/s Abbott

12.52


Sl.

No.

Name of the Formulation / Brand Name

Strength

Unit

Manufacturer & Marketing Company

Retail Price (Rs.)

(1)

(2)

(3)

(4)

(5)

(6)

Tablets

Bisoprolol Fumarate IP 5mg

Healthcare Pvt. Ltd.

45

Telmisartan and Bisoprolol Fumarate Tablets

Each film coated tablet contains:

Telmisartan IP 40mg Bisoprolol Fumarate IP

2.5mg

1 Tablet

M/s Ravenbhel Healthcare Pvt. Ltd.

/ M/s Abbott Healthcare Pvt. Ltd.

10.92

46

Indacaterol and Budesonide Inhalation

Each actuation delivers: Indacaterol Maleate eq. to

Indacaterol 75mcg Budesonide IP 200mcg

Per MDI

M/s Zydus Healthcare Limited

35.22

47

Indacaterol and Budesonide Powder for Inhalation

Each capsule contains: Indacaterol Maleate eq. to Indacaterol 75mcg Budesonide IP 200mcg

Per DPI

M/s Zydus Healthcare Limited

36.22

48

Indacaterol and Budesonide Powder for Inhalation

Each capsule contains: Indacaterol Maleate eq. to Indacaterol 150mcg Budesonide IP 400mcg

Per DPI

M/s Zydus Healthcare Limited

60.71

49

Atorvastatin and Clopidogrel Tablets

Each uncoated bilayere tablet contains: Atorvastatin Calcium IP eq. to Atorvastatin 40 mg

Clopidogrel Bisulphate IP eq.

to Clopidogrel 75 mg

1 Tablet

M/s Pure & Cure Healthcare Pvt. Ltd.

/ M/s Sun Pharmaceuticals Industries Ltd.

27.60

50

Atorvastatin and Clopidogrel Tablets

Each uncoated bilayered tablet contains: Atorvastatin Calcium IP eq. to Atorvastatin 40 mg

Clopidogrel Bisulphate IP eq.

to Clopidogrel 75 mg

1 Tablet

M/s Pure & Cure Healthcare Pvt. Ltd.

/ M/s Sun Pharma Laboratories Limited

27.60

51

Atovastatin and Clopidogrel Tablets

Each uncoated bilayered tablet contains: Atorvastatin Calcium IP eq. to Atorvastatin 40 mg

Clopidogrel Bisulphate IP eq.

to Clopidogrel 75 mg

1 Tablet

M/s Pure & Cure Healthcare Pvt. Ltd.

27.60

52

Bilastine and Montelukast Ondispersible Tablets

Each uncoated Orodispersible tablet contains:

Montelukast Sodium IP Eq. to Montelukast 4mg

Bilastine 10mg

1 Tablet

M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Cipla Ltd.

14.38

53

Lobeglitazone Sulphate and Metformin Hydrochloride Extended- Release Tablets

Each uncoated bilayer tablet contains:

Lobeglitazone Sulphate 0.5mg

Metformin Hydrochloride IP 500mg (as Extended

Release)

1 Tablet

M/s Glenmark Pharmaceuticals Limited

9.90

54

Lobeglitazone Sulfate and Metformin

Each uncoated bilayer tablet contains:

Lobeglitazone Sulfate 0.5mg

1 Tablet

M/s Glenmark Pharmaceuticals Limited

11.44


Sl.

No.

Name of the Formulation / Brand Name

Strength

Unit

Manufacturer & Marketing Company

Retail Price (Rs.)

(1)

(2)

(3)

(4)

(5)

(6)

Hydrochloride Extended Release Tablets

Metformin Hydrochloride IP 1000mg (as Extended Release)

55

Paracetamol, Phenylephrine Hydrochloride, Chlorpheniram ine maleate, Ammonium Chloride, Sodium Citrate & Menthol Suspension

Each 5ml (teaspoonful) contains:

Paracetamol IP 250mg Phenylephrine Hydrochloride IP 5mg Chlorpheniramine maleate IP 2mg

Ammonium Chloride IP 120mg

Sodium Citrate IP 60mg

Menthol IP 1mg

1 ml

M/s Windlas Biotech Limited / M/s Torrent Pharmaceuticals Limited

0.89

56

Amoxycillin and Potassium Clavulanate Tablets IP

Each film coated tablet contains:

Amoxycillin Trihydrate eq. to Amoxycillin IP 875mg Potassium Clavulanate

Diluted eq. to Clavulanic Acid IP 125mg

1 Tablet

M/s Alps Communications Pvt. Ltd. / M/s Aristo Laboratories Pvt. Ltd.

34.68

57

Amoxycillin and Potassium Clavulanate Oral suspension

Each 5ml reconstituted suspension contains: Amoxycillin Trihydrate eq. to Amoxycillin IP 400mg Potassium Clavulanate Diluted eq. to Clavulanic Acid

IP 57mg

1 ml

M/s Alps Communications Pvt. Ltd. / M/s Aristo Laboratories Pvt. Ltd.

3.97

58

Cefixime and Ofloxacin Tablets

Each film coated tablet contains:

Cefixime eq. to Cefixime

Anhydrous IP 200mg Ofloxacin IP 200mg

1 Tablet

M/s Alps Communications Pvt. Ltd. / M/s

Aristo Laboratories Pvt. Ltd.

12.74

59

Bilastine and Montelukast Oral Suspenssion

Each 5ml suspension contains:

Bilastine 10mg

Montelukast Sodium IP eq. to

Monelukast 4mg

1 ml

M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Zuventus Healthcare Limited

1.71

60

Bilastine and Montelukast Oral Suspenssion

Each 5ml suspension contains:

Bilastine 10mg

Montelukast Sodium IP eq. to Monelukast 4mg

1 ml

M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Emcure

Pharaceuticals Limited

1.71

61

Amoxycillin & Potassium Clavulanate Oral Suspension IP 457mg

Each 5ml of reconstituted suspension contains: Amoxycillin trihydrate IP eq. to Amoxycillin 400mg Potassium Clavulanate Diluted IP eq. to Clavulanic

Acid 57mg

1 ml

M/s Medicef Pharma / M/s Troikaa Pharmaceuticals Ltd.

3.90

62

Dextromethorphan hydrobromide,

Each 5ml contains:

Dextromethorphan Hydrobromide IP 5mg

1 ml

M/s Pure and Cure Healthcare Pct. Ltd.

/ M/s German

0.86


Sl.

No.

Name of the Formulation / Brand Name

Strength

Unit

Manufacturer & Marketing Company

Retail Price (Rs.)

(1)

(2)

(3)

(4)

(5)

(6)

Chlorpheniram ine Meleate & Phenylephrine Hydrochloride Syrup

Chlorpheniramine Meleate IP 1mg

Phenylephrine Hydrochloride IP 2.5mg

Remedies Pharmaceuticals Pvt. Ltd.

63

Dextromethor phan hydrobromide, Chlorpheniram ine Meleate & Phenylephrine Hydrochloride Syrup

Each 5ml contains: Dextromethorphan Hydrobromide IP 15mg Chlorpheniramine Meleate IP 2mg

Phenylephrine Hydrochloride IP 5mg

1 ml

M/s Pure and Cure Healthcare Pct. Ltd.

/ M/s German Remedies Pharmaceuticals Pvt. Ltd.

0.87

64

Aceclofenac, Paracetamol & Serratiopeptid ase Tablets

Each Film Coated Tablet contains:

Aceclofenac IP 100mg Paracetamol IP 325mg

Serratiopeptidase IP 15mg

1 Tablet

M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Torrent Pharmaceuticals Ltd.

7.78

65

Desvenlafaxine Extended release and Clonazepam Tablets

Each uncoated bilayered tablet contains: Desvenlafaxine Succinate USP eq. to Desvenlafaxine 50mg (As Extended release form)

Clonazepam IP 0.25mg

1 Tablet

M/s Pure and Cure Healthcare Pvt. Ltd.

13.24

66

Trastuzumab 150mg

Combipack of

Each pack contains:

Vial-I

Lyophilized Powder for concentrate for solution for Intravenous Infusion, Multi use vial

Composition:

Trastuzumab (r-DNA Origin) IH (Active ingredient) 150mg,

α,α-Trehalose Dihydrate USP (as Lyoprotectant) 136.2mg L-Histidine Hydrochloride Monohydrate EP (as buffering agent) 3.36mg

L-Histidine USP (as buffering agent) 2.16mg

Polysorbate 20 IP (as surfactant) 0.6mg Vial -2

Bacteriostatic Water for Injection 10 ml

Single use vial Composition:

Benzyl Alcohol IP 1.1% V/V Water for Injection

1 ml

M/s Hetero Biopharma Ltd. / M/s Hetero Healthcare Ltd.

15522.

32

67

Aceclofenac, Paracetamol

Each Film Coated Tablet

contains:

1 Tablet

M/s Theon

Pharmaceuticals

7.78


Sl.

No.

Name of the Formulation / Brand Name

Strength

Unit

Manufacturer & Marketing Company

Retail Price (Rs.)

(1)

(2)

(3)

(4)

(5)

(6)

and Serratiopeptid ase tablets

Aceclofenac IP 100mg Paracetamol IP 325mg Serratiopeptidase IP 15mg

Limited / M/s Zydus Healthcare Limited

68

Trypsin- Chymotrypsin, Paracetamol & Aceclofenac Tablets

Each Film coated tablet contains:

50000 Armour Units of Enzymatic Activity (Supplied by a Purified Concentrate which has specific Trypsin & Chymotrypsin Activity in a Ratio of Approximately Six One)(As enteric coated granules)

Paracetamol IP 325 Aceclofenac IP 100mg

1 Tablet

M/s Biogenetic Drugs Pvt. Ltd. / M/s Lupin Limited

9.84

69

Cilnidipine, Telmisartan & Chlorthalidone Tablets

Each film coated tablet contains:

Cilnidipine IP 10mg Telmisartan IP 40mg

Chlorthalidone IP 12.50mg

1 Tablet

M/s Pure and Cure Healthcare Pvt. Ltd.

/ M/s Aristo Pharmaceuticals

Pvt. Ltd.

13.72

70

Paclitaxel (protein bound particles) for Injectable Suspension (Lyophilized)

Each Vial contains: Paclitaxel IP 100mg Human Albumin IP

approximately 900mg (After reconstitution)

1 vial

M/s Samarth Life Sciences Pvt. Ltd.

5866.7

6

71

Ferrous Fumarate, Folic Acid and Cyanocobalami n Syrup

Each 5ml contains:

Ferrous Fumarate IP 100mg eq. to Elemental Iron 32.8mg Folic Acid IP 0.5mg

Cyanocobalamin (Vitamin B12) IP5mcg

I ml

M/s Zydus Healthcare Limited

0.55

72

Amoxycillin and Potassium Clavulanate Tablets IP

Each film coated tablet contains:

Amoxycillin Trihydrate eq. to Amoxycillin IP 250mg Potassium Clavulanate Diluted eq. to Clavulanic Acid

IP 125mg

1 Tablet

M/s Alps Communications Pvt. Ltd. / M/s Aristo Laboratories Pvt. Ltd.

16.15

73

Amoxycillin, Dicloxacillin & Lactic Acid Bacillus Capsule

Each hard gelation contains: Amoxycillin Trihydrate IP eq. to Amoxycillin 250mg Dicloxacillin Sodium IP eq. to Dicloxacillin 250mg

Lactic Acid Bacillus 2.5 billion Spores

1

Capsule

M/s Akums Drugs & Pharmaceuticals Ltd. / M/s German Remedies Pharmaceuticals Private Limited

8.77

74

Multivitamin Tablets with Mineral and Trace Element

Each sugar coated tablet contains:

Vitamin A (As Acetate) IP 10000 IU.

Cholecalciferol IP 1000 IU (In Stabilized form… ) Thiamine Mononitrate IP 10mg

1 Tablet

M/s Aristo Pharmaceuticals Pvt. Ltd.

1.88


Sl.

No.

Name of the Formulation / Brand Name

Strength

Unit

Manufacturer & Marketing Company

Retail Price (Rs.)

(1)

(2)

(3)

(4)

(5)

(6)

Riboflavin IP 10mg Pyridoxine Hydrochlorie IP 3mg

Cyanocobalamin IP 15mcg Nicotinaminde IP 100mg Calcium Pantothenate IP 16.30mg

Ascorbic Acid IP 150mg α Tocopheryl Acetate IP 25mg

Biotin USP 0.25mg

Tribasic Calcium Phosphate IP 129mg

Light Magnesium Oxide IP 60mg

Dried Ferrous Sulphate IP 32.04mg

Manganese Sulphate Monohydrate BP 2.03mg Total Phosphorus in the preparation 25.80mg Copper Suphate Pentahydrate BP 3.39mg Zinc Sulphate IP 2.20mg

Sodium Molybdate Dihydrate BP 0.25mg

Sodium Borate BP 0.88mg

Note:

(a) The manufacturer of the above-mentioned formulations i.e., “new drug” under paragraph 2(1)(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove.

(b) The manufacturer may add Goods and Services Tax only if they have paid actually or it is payable to the Government on the retail price mentioned in column (6) of the above-said table.

(c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V from the date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.

(d) As per para 24(4) of DPCO 2013, every retailer and dealer shall display the price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.

(e) The above-mentioned retail price is applicable only to the individual manufacturer/marketer as mentioned above i.e. who has applied for the same by submitting Form-I for price fixation/revision as stipulated under DPCO, 2013 and subject to fulfilment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, including manufacturing license permission from the Competent Authority i.e. the Central/State Licensing Authority, as may be applicable, by the concerned manufacturer/marketing companies.

(f) In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.

(g) Consequent to the fixation of the retail price of such formulation as specified in column (2) of the above table with the strength and name of Manufacturer & Marketing Companies specified in the corresponding entries in Columns (3) & (5) thereof, the price order(s) fixing the retail price of the formulation with specified strength for that Manufacturer & Marketing Companies as specified in corresponding entries in Column (2), (3) and (5) thereof, if any, issued prior to this notification, stand(s) superseded.

Also Read: CDSCO panel nod to Sun Pharma to manufacture, market antidiabetic FDC drug

npparetail priceprice fixationsun phamamankind pharma
Dr. Divya Colin
Dr. Divya Colin

    Doctor of Pharmacy

    Dr. Divya Colin, a Doctor of Pharmacy Graduate with extensive experience in clinical and hospital settings and confidently equipped with diagnostic and therapeutic skills. She also has spread out exposure to Oncology Departments in Mysore Medical College and Research Institute as Oncology Pharmacist. Currently she is building a career in clinical research and clinical data management. She has been a part of Medical Dialogue since January 2022.

    Show Full Article
    Next Story

    Editorial

    Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in Metastatic Breast Cancer - Dr Aditya Murali

    Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in Metastatic Breast Cancer...

    Aspirin in Primary Prevention- When to Consider?

    Aspirin in Primary Prevention- When to Consider?

    Featured image representing medico legal

    What's the Role of Expert Opinion in Medical Negligence?

    7- Point Discharge Protocol for AECOPD: Time to Inculcate in Practice

    7- Point Discharge Protocol for AECOPD: Time to Inculcate in Practice

    Aspirin Use in Women Aged 40-50 with Diabetes and Hypertension: Identifying the Ideal Candidates

    Aspirin Use in Women Aged 40-50 with Diabetes and Hypertension: Identifying the Ideal Candidates

    View All

    Journal Club Today

    Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in Metastatic Breast Cancer - Dr Aditya Murali

    Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in Metastatic Breast Cancer...

    View All

    Health News Today

    Health Bulletin 09/ May/ 2025

    Health Bulletin 09/ May/ 2025

    View All
    © 2022 All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok